[EN] COMPOUNDS FOR THE DEGRADATION OF BRD9 OR MTH1<br/>[FR] COMPOSÉS POUR LA DÉGRADATION DE BRD9 OU MTH1
申请人:C4 THERAPEUTICS INC
公开号:WO2020051235A1
公开(公告)日:2020-03-12
Compounds that degrade BRD9 or MTH1 via the ubiquitin proteasome pathway in a subject in need thereof for therapeutic applications are provided. The compounds provided have an E3 Ubiquitin Ligase targeting moiety (Degron) that is linked to a Targeting Ligand for BRD9 or MTH1.